• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常乳腺上皮细胞与癌细胞共培养的致癌转化。

Oncogenic transformation of normal breast epithelial cells co-cultured with cancer cells.

机构信息

a Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine , Chinese Academy of Medical Sciences and Peking Union Medical College , Tianjin , China.

b Department of Endocrinology and Metabolism, Xijing Hospital , The Fourth Military Medical University , Xi'an , China.

出版信息

Cell Cycle. 2018;17(16):2027-2040. doi: 10.1080/15384101.2018.1511510. Epub 2018 Sep 18.

DOI:10.1080/15384101.2018.1511510
PMID:30160604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6224270/
Abstract

The heterogeneity in human breast cancer poses a challenge for effective treatment. Better understanding of tumor initiation and development will help to resolve this problem. Current models explaining intratumoral diversity include cancer stem cells, clonal evolution and cancer cell dedifferentiation and reprogramming. Herein, a new model, cancer transmission, is proposed to explain cancer heterogeneity. We found breast cancer cells (MCF10A.NeuT) were capable of transforming normal mammary epithelial cells (MCF10A). The transformed cells exhibited cancerous properties including enhanced proliferation and migration, loss of apical-basal polarity and depolarized acini structure associated with epithelial-mesenchymal transition (EMT). The transformed MCF10A cells displayed distinct EMT characteristics compared to parental cells. We further showed that cancer cell-secreted factors were sufficient to induce cancerous transformation of normal cells. Furthermore, transformed cells were resistant to radiation treatment, providing new insights into mechanisms underlying therapeutic resistance.

摘要

人类乳腺癌的异质性对有效治疗构成了挑战。更好地了解肿瘤的发生和发展将有助于解决这个问题。目前解释肿瘤内异质性的模型包括癌症干细胞、克隆进化以及癌细胞去分化和重编程。在此,提出了一种新的模型——癌症传播,以解释癌症的异质性。我们发现乳腺癌细胞(MCF10A.NeuT)能够转化正常乳腺上皮细胞(MCF10A)。转化后的细胞表现出癌症特性,包括增强的增殖和迁移、顶端-基底极性丧失以及与上皮-间充质转化(EMT)相关的去极化小腔结构。与亲本细胞相比,转化的 MCF10A 细胞表现出明显的 EMT 特征。我们进一步表明,癌细胞分泌的因子足以诱导正常细胞的癌变转化。此外,转化细胞对放射治疗具有抗性,为治疗抵抗的机制提供了新的见解。

相似文献

1
Oncogenic transformation of normal breast epithelial cells co-cultured with cancer cells.正常乳腺上皮细胞与癌细胞共培养的致癌转化。
Cell Cycle. 2018;17(16):2027-2040. doi: 10.1080/15384101.2018.1511510. Epub 2018 Sep 18.
2
Conditioned Medium from Malignant Breast Cancer Cells Induces an EMT-Like Phenotype and an Altered N-Glycan Profile in Normal Epithelial MCF10A Cells.来自恶性乳腺癌细胞的条件培养基可诱导正常上皮MCF10A细胞呈现上皮-间质转化样表型并改变N-聚糖谱。
Int J Mol Sci. 2017 Aug 1;18(8):1528. doi: 10.3390/ijms18081528.
3
PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.PRRX2作为一种新的转化生长因子β诱导因子,增强乳腺上皮细胞的侵袭和迁移能力,并与乳腺癌的不良预后相关。
Mol Carcinog. 2016 Dec;55(12):2247-2259. doi: 10.1002/mc.22465. Epub 2016 Jan 29.
4
Loss of PTPN12 Stimulates Progression of ErbB2-Dependent Breast Cancer by Enhancing Cell Survival, Migration, and Epithelial-to-Mesenchymal Transition.蛋白酪氨酸磷酸酶N12(PTPN12)的缺失通过增强细胞存活、迁移及上皮-间质转化促进erbB2依赖性乳腺癌的进展。
Mol Cell Biol. 2015 Dec;35(23):4069-82. doi: 10.1128/MCB.00741-15. Epub 2015 Sep 21.
5
HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR.表皮生长因子受体(EGFR)的共表达可抑制人表皮生长因子受体2(HER2)在乳腺上皮祖细胞中诱导的上皮-间质转化(EMT)和致瘤性。
Oncogene. 2016 Aug 11;35(32):4244-55. doi: 10.1038/onc.2015.489. Epub 2015 Dec 21.
6
Decreased eIF3e/Int6 expression causes epithelial-to-mesenchymal transition in breast epithelial cells.eIF3e/Int6 表达降低导致乳腺上皮细胞发生上皮间质转化。
Oncogene. 2013 Aug 1;32(31):3598-605. doi: 10.1038/onc.2012.371. Epub 2012 Aug 20.
7
Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.乳腺癌相关成纤维细胞诱导乳腺癌细胞发生上皮间质转化。
Endocr Relat Cancer. 2013 Jan 7;20(1):1-12. doi: 10.1530/ERC-12-0227. Print 2013 Feb.
8
Baicalin and baicalein inhibit transforming growth factor-β1-mediated epithelial-mesenchymal transition in human breast epithelial cells.黄芩苷和黄芩素抑制转化生长因子-β1介导的人乳腺上皮细胞上皮-间质转化。
Biochem Biophys Res Commun. 2015 Mar 13;458(3):707-713. doi: 10.1016/j.bbrc.2015.02.032. Epub 2015 Feb 14.
9
SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.SOX4 诱导上皮-间充质转化,促进乳腺癌进展。
Cancer Res. 2012 Sep 1;72(17):4597-608. doi: 10.1158/0008-5472.CAN-12-1045. Epub 2012 Jul 11.
10
Breast cancer stem cells: obstacles to therapy.乳腺癌干细胞:治疗的障碍。
Cancer Lett. 2013 Sep 10;338(1):57-62. doi: 10.1016/j.canlet.2012.04.023. Epub 2012 Apr 30.

引用本文的文献

1
Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assay.使用CA15-3捕获抗体-凝集素夹心测定法改进乳腺癌诊断。
Breast Cancer Res Treat. 2025 Jun;211(3):605-615. doi: 10.1007/s10549-025-07672-z. Epub 2025 Mar 27.
2
Epithelial cell-related prognostic risk model in breast cancer based on single-cell and bulk RNA sequencing.基于单细胞和批量RNA测序的乳腺癌上皮细胞相关预后风险模型
Heliyon. 2024 Aug 28;10(17):e37048. doi: 10.1016/j.heliyon.2024.e37048. eCollection 2024 Sep 15.
3
Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles.

本文引用的文献

1
IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma.胰岛素样生长因子结合蛋白2激活核因子-κB通路,驱动胰腺导管腺癌的上皮-间质转化和侵袭特性。
Cancer Res. 2016 Nov 15;76(22):6543-6554. doi: 10.1158/0008-5472.CAN-16-0438. Epub 2016 Sep 22.
2
Endocrine treatment in breast cancer: Cure, resistance and beyond.乳腺癌的内分泌治疗:治愈、耐药及其他。
Cancer Treat Rev. 2016 Nov;50:68-81. doi: 10.1016/j.ctrv.2016.08.008. Epub 2016 Sep 7.
3
Quantification of HER2 heterogeneity in breast cancer-implications for identification of sub-dominant clones for personalised treatment.
肿瘤细胞衍生的细胞外囊泡对肿瘤微环境的调控作用。
Cells. 2024 Apr 15;13(8):682. doi: 10.3390/cells13080682.
4
Breast cancer heterogeneity and its implication in personalized precision therapy.乳腺癌异质性及其在个性化精准治疗中的意义。
Exp Hematol Oncol. 2023 Jan 9;12(1):3. doi: 10.1186/s40164-022-00363-1.
5
Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells.肿瘤衍生细胞外囊泡对正常细胞恶性转化的作用
Bioengineering (Basel). 2022 Jun 4;9(6):245. doi: 10.3390/bioengineering9060245.
6
Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery.乳腺癌诊断与脑转移之间的时间间隔影响转移手术后的预后。
J Neurooncol. 2022 Aug;159(1):53-63. doi: 10.1007/s11060-022-04043-2. Epub 2022 Jun 7.
7
MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer.miR-509-3p 是致癌基因,靶向肿瘤抑制因子 PHLPP2,并作为结直肠癌新型肿瘤旁正常组织预后生物标志物发挥作用。
BMC Cancer. 2022 Mar 31;22(1):351. doi: 10.1186/s12885-021-09075-x.
8
Graphene Quantum Dot-Based Electrochemical Immunosensors for Biomedical Applications.用于生物医学应用的基于石墨烯量子点的电化学免疫传感器。
Materials (Basel). 2019 Dec 23;13(1):96. doi: 10.3390/ma13010096.
乳腺癌中HER2异质性的定量分析——对识别用于个性化治疗的亚优势克隆的意义
Sci Rep. 2016 Mar 21;6:23383. doi: 10.1038/srep23383.
4
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.通过表观遗传和翻译后修饰调控上皮-间质转化
Mol Cancer. 2016 Feb 24;15:18. doi: 10.1186/s12943-016-0502-x.
5
Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments.肿瘤干细胞:放射抵抗性、放疗效果预测及联合治疗的特异性靶点。
Adv Drug Deliv Rev. 2017 Jan 15;109:63-73. doi: 10.1016/j.addr.2016.02.002. Epub 2016 Feb 12.
6
Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR.癌细胞通过可溶性E-钙黏蛋白介导的表皮生长因子受体激活,诱导上皮细胞发生管腔填充和上皮-间质转化。
J Cell Sci. 2015 Dec 1;128(23):4366-79. doi: 10.1242/jcs.173518. Epub 2015 Oct 19.
7
How cancer cells hijack DNA double-strand break repair pathways to gain genomic instability.癌细胞如何劫持DNA双链断裂修复途径以获得基因组不稳定。
Biochem J. 2015 Oct 1;471(1):1-11. doi: 10.1042/BJ20150582.
8
Toward understanding and exploiting tumor heterogeneity.迈向对肿瘤异质性的理解与利用。
Nat Med. 2015 Aug;21(8):846-53. doi: 10.1038/nm.3915.
9
Clonal evolution in cancer: a tale of twisted twines.癌症中的克隆进化:纠结的蔓藤。
Cell Stem Cell. 2015 Jan 8;16(1):11-2. doi: 10.1016/j.stem.2014.12.011.
10
Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis.癌症外泌体可进行非细胞依赖的微小RNA生物合成并促进肿瘤发生。
Cancer Cell. 2014 Nov 10;26(5):707-21. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.